Health Care · NYSE: HCA
HCA Healthcare earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 26 Jan 2027
Latest: Q3 2026
HCA grew volumes for a 22nd straight quarter on emergency, neonatal and ambulatory demand, even as lost exchange coverage pushed more patients into uninsured status.
HCA's patient volumes kept growing, led by emergency room visits, neonatal, cardiac and trauma care, while elective surgery stayed weak. Many patients who lost health insurance exchange coverage became uninsured almost one-for-one, and uninsured patients reached about 10.5 % of equivalent admissions. Insured demand grew faster than in the first half of the year. Hospitals are running at record occupancy, and management is adding beds and expanding its outpatient network.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $18.3B * |
| Q1 2025 | $18.3B |
| Q2 2025 | $18.6B |
| Q3 2025 | $19.2B |
| Q4 2025 | $19.5B * |
| Q1 2026 | $19.1B |
| Q2 2026 | $20.2B |
| Q3 2026 | $19.8B |
Data
| Q1 2025 | $6.45 |
| Q2 2025 | $6.83 |
| Q3 2025 | $6.96 |
| Q1 2026 | $7.15 |
| Q2 2026 | $7.62 |
| Q3 2026 | $7.27 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | $1.3B |
| Q1 2025 | $660.0M |
| Q2 2025 | $3.0B |
| Q3 2025 | $3.1B |
| Q4 2025 | $870.0M |
| Q1 2026 | $895.0M |
| Q2 2026 | $1.1B |
| Q3 2026 | $3.1B |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.3Bd | $18.3B | $18.6B | $19.2B | $19.5Bd | $19.1B | $20.2B | $19.8B |
| Net income | $1.4Bd | $1.6B | $1.7B | $1.6B | $1.9Bd | $1.6B | $1.7B | $1.6B |
| Diluted EPS | — | $6.45 | $6.83 | $6.96 | — | $7.15 | $7.62 | $7.27 |
| Operating cash flow | $2.6Bd | $1.7B | $4.2Bd | $4.4Bd | $2.4Bd | $2.0B | $2.3Bd | $4.5Bd |
| Capital expenditure | $1.3Bd | $991.0M | $1.2Bd | $1.3Bd | $1.5Bd | $1.1B | $1.2Bd | $1.4Bd |
| Free cash flow | $1.3B | $660.0M | $3.0B | $3.1B | $870.0M | $895.0M | $1.1B | $3.1B |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-K and 10-Q filings
- 29 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 28 Jul 202610-Q for the period ended 30 Jun 2026SEC ↗
- 29 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 10 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 30 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 4 Aug 202510-Q for the period ended 30 Jun 2025SEC ↗
- 1 May 202510-Q for the period ended 31 Mar 2025SEC ↗
- 14 Feb 202510-K for the period ended 31 Dec 2024SEC ↗